Cargando…
N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
BACKGROUND: Accumulating evidence has revealed the critical roles of N(6)-methyladenosine (m(6)A) modification of mRNA in various cancers. However, the biological function and regulation of m(6)A in bladder cancer (BC) are not yet fully understood. METHODS: We performed cell phenotype analysis and e...
Autores principales: | Jin, Huan, Ying, Xiaoling, Que, Biao, Wang, Xiaoxue, Chao, Yinghui, Zhang, Haiqing, Yuan, Zusen, Qi, Defeng, Lin, Shuibin, Min, Wang, Yang, Mei, Ji, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796523/ https://www.ncbi.nlm.nih.gov/pubmed/31409574 http://dx.doi.org/10.1016/j.ebiom.2019.07.068 |
Ejemplares similares
-
Dynamic m(6)A mRNA methylation reveals the role of METTL3-m(6)A-CDCP1 signaling axis in chemical carcinogenesis
por: Yang, Fan, et al.
Publicado: (2019) -
Programmable N6-methyladenosine modification of CDCP1 mRNA by RCas9-methyltransferase like 3 conjugates promotes bladder cancer development
por: Ying, Xiaoling, et al.
Publicado: (2020) -
N(6)-methyladenosine (m(6)A) RNA modification in tumor immunity
por: Zheng, Siyi, et al.
Publicado: (2022) -
Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma
por: Feng, Chen, et al.
Publicado: (2020) -
METTL1‐m(7)G‐EGFR/EFEMP1 axis promotes the bladder cancer development
por: Ying, Xiaoling, et al.
Publicado: (2021)